Rapacan 1mg Tablets

About Rapacan 1mg Tablets

Rapacan 1mg Tablets contain Sirolimus, an immunosuppressive drug used to prevent organ rejection in transplant patients. It is commonly prescribed after kidney, liver, or heart transplants. Sirolimus works by inhibiting the activation and proliferation of T cells, which are involved in the immune response that can lead to transplant rejection.

Key Uses:

1. Organ Transplantation: After a kidney transplant, Rapacan 1mg helps prevent organ rejection by suppressing the immune system.
2. Autoimmune Conditions: In some cases, it may be used for other autoimmune conditions or certain types of cancers.

Mechanism of Action:

Sirolimus blocks the action of a protein called mTOR (mechanistic target of rapamycin), which is essential for cell growth, proliferation, and survival. By inhibiting mTOR, Rapacan reduces the ability of immune cells to divide and attack the transplanted organ.

Common Side Effects:

• Increased risk of infections due to immune suppression.
• Nausea, vomiting, or diarrhea.
• High blood pressure and elevated cholesterol levels.
• Liver problems and kidney issues may occur, requiring monitoring.

Dosage:

The dosage of Rapacan 1mg is individualized based on the patient's condition and response to treatment. Regular blood tests are necessary to monitor the drug's effectiveness and avoid toxicity.

Patients taking Rapacan should follow their healthcare provider™s instructions closely and attend scheduled follow-up appointments for monitoring.